Page 388 - AIDSBK23C
P. 388
Page 388
1124 Stramer SL, Glynn SA, Kleinman SH, et al. Detection of HIV-1 and HCV infections
among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J
Med. 2004;351:760-768.
1125 Jackson BR, Busch MP, Stramer SL, AuBuchon JP. The cost-effectiveness of NAT for
HIV, HCV, and HBV in whole-blood donations. Transfusion. 2003;43:721-729.
1126 Litvak E, Siegel JE, Pauker SG, Lallemant M, Fineberg HV, Weinstein MC. Whose
blood is safer? The effect of the stage of the epidemic on screening for HIV. Med Decis
Making. 1997;17:455-463.
1127 Urwijitaroon Y, Barusrux S, Romphruk A, Puapairoj C, Pakote L. Reducing the risk of
HIV transmission through blood transfusion by donor self-referral. Southeast Asian J
Trop Med Public Health. 1996;27:452-456.
1128 Pink J, Thomson A, Wylie B. Infectious disease markers in autologous and directed
donations. Transfus Med. 1994;4:135-138.
1129 Burnouf T. Modern plasma fractionation. Transfus Med Rev. 2007;21:101-117.
1130 Bierig JR. Legal issues for blood banks. Arch Pathol Lab Med. 1994;118:442-453.
1131 Collier AC, Kalish LA, Busch MP, et al. Leukocyte-reduced red blood cell transfusions
in patients with anemia and human immunodeficiency virus infection. JAMA.
2001;285:1592-1601.
1132 Yao F, Seed C, Farrugia A, Morgan D, Cordner S, Wood D, Zheng MH. The risk of HIV,
HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia. Am J
Transplant. 2007;7:2723-2726.
1133 Ahn J, Cohen SM. Transmission of human immunodeficiency virus and hepatitis C virus
through liver transplantation. Liver Transpl. 2008;14:1603-1608.
1134 Centers for Disease Control. Guidelines for preventing transmission of human
immunodeficiency virus through transplantation of human tissues and organs. MMWR.
1994;43(RR-8):1-17.
1135 Simonds RJ. HIV transmission by organ and tissue transplantation. AIDS. 1993;7(Suppl
2):S35-S38.
1136 Smith RA, Ingels J, Lochemes JJ, Dutkowsky JP, Pifer LL. Gamma irradiation of HIV-1.
J Orthop Res. 2001;19:815-819.
